Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent

By Dorothy Atkins · July 26, 2022, 9:16 PM EDT

A Delaware federal jury found Tuesday that Kurin Inc.'s blood-testing products infringe Magnolia Medical Technologies Inc.'s blood-testing patent in the first phase of the two-part jury trial, sending the case to...

To view the full article, register now.